• Responsible for search and evaluation of new technologies (cell engineering, vector engineering, process technologies) to increase company capabilities. Work alongside the BD team to screen potential collaborations or partnerships in terms of scientific strength and potential applicability to the CGT field.

Lead process development activities for both company programs, developing internal processes for production and purification of AAV and leading tech transfer activities to CMO/CDMOs.

• Function as a freelance consultant specializing in aiding clients with their process development/manufacturing and gene therapy analytics problems and general knowledge gaps or advising on market/technology gaps (manufacturing capacity and/or technology) for Cell and Gene therapies. Assist in solving difficult research/product development issues at the early platform stage.

• Established Ring Tx’s key viral vector platform design (now utilized company-wide) that overcame the existing limitations of the 1st generation platform through implementing novel construct modifications, protein engineering strategies and establishing/leading a cross functional team composed of Scientists from different depts. To re-engineering Rings key technology